GlassScriptPhysician profile
Anne Marie Rose
NPI 1942754767
$930.05
in general payments reported to CMS, 2019-2025
20 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $287 · 2023: $147 · 2024: $156 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511 · Education: $1.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.84 |
| Education | $1.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $160.78 | 2022-2025 | Xyosted |
| Myovant Sciences INC. | $112.76 | 2021-2022 | |
| Astellas Pharma US INC | $92.86 | 2022-2024 | Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $65.83 | 2023-2025 | Gemtesa |
| Abbvie INC. | $58.24 | 2022-2023 | |
| Medtronic, INC. | $44.67 | 2022 | |
| Laborie Medical Technologies Corp. | $43.18 | 2025 | Flowstar |
| Abiomed | $40.36 | 2024 | Impella |
| Rochester Medical Corporation | $40.36 | 2021 | |
| Myriad Genetic Laboratories, INC. | $39.79 | 2022-2023 | Prolaris |
| Boston Scientific Corporation | $39.24 | 2025 | Ams 700 |
| Urogen Pharma, INC. | $36.64 | 2024 | |
| Procept Biorobotics Corporation | $35.24 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $25.58 | 2023 | Uptravi, Opsumit |
| Pfizer INC. | $19.96 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $19.85 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.21 | 2025 | |
| Coloplast Corp | $17.34 | 2024 | |
| Teleflex LLC | $17.06 | 2023 | Urolift |
| Travere Therapeutics, INC. | $1.10 | 2023 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.